Arbutus Biopharma Corp (NQ: ABUS )
3.870
+0.040
(+1.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
All News about Arbutus Biopharma Corp
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
Arbutus to Participate in Three Upcoming Investor Conferences
February 06, 2023
Via GlobeNewswire
Arbutus Biopharma's Return On Capital Employed Insights
December 12, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_7956.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_5517.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
Arbutus Announces Resignation of Board Member
January 27, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/12/06/pfizer-biontech_covid-19_vaccine_2020_g.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
Arbutus to Present at Jefferies London Healthcare Conference
November 08, 2022
Via GlobeNewswire
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
![](https://ml.globenewswire.com/media/be474abd-3f6d-4270-a58e-1e6ee5c80bb2/small/arbutus-biopharma-logo.jpg)
Via GlobeNewswire
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/08/26/moderna_covid-19_vaccine_2021_g.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/04/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/07/21/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-pfizervaccine-02-adobe.jpg)
![](https://www.investors.com/wp-content/uploads/2020/12/Stock-pfizervaccine-02-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/06/28/aapharma_9.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/09/nyse_trading_floor-wikimedia.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/09/covid_moderna_-_photo_by_mufidpwt_via_pixaby.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/05/05/cells-gdd37bc5d2_1920.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_4328.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/covid-19-vaccine-image_by_x3_from_pixabay_46.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/roce_image_570.jpeg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.